Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


Dates: 2015-ongoing
Funding: Health Economics Research Centre, University of Oxford
Collaborators: Dmitrij Achelrod, Hamburg University; David Preiss, University of Oxford

Cholesterol- and blood pressure-lowering medications, shown to be effective and cost-effective in reducing cardiovascular risk and recommended in clinical guidelines, have been at the forefront of cardiovascular prevention. However, whilst improving, their use has remained suboptimal even in high-income countries with comprehensive healthcare provision. The aim of the project is to investigate the trends of use of cholesterol- and blood pressure lowering interventions and the role of socioeconomic, behavioural and cognitive factors using large population surveys.


Borislava Mihaylova

Associate Professor and University Research Lecturer

+44 (0)1865 289226

Alastair Gray

Professor of Health Economics, Director, HERC

+44 (0)1865 289279


Achelrod D, Gray A, Preiss D, Mihaylova B. Cholesterol and blood-pressure lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe. Eur J Prev Cardiol 2016:2047487316676906.